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Rhodococcus equi and Dietzia spp. are closely related actinomycetes that show similar phenotypic properties.
In humans, R. equi is an opportunistic pathogen associated with severe immunodeficiency. Dietzia spp. are
environmental bacteria that have been isolated recently from clinical material and are presumptively associ-
ated with human infections. During the last 5 years, 15 bacterial isolates from human clinical samples collected
at the Hospital Marque´s de Valdecilla, Santander, Spain, were identified as R. equi by the API Coryne test. 16S
rRNA gene sequencing confirmed seven isolates to be true R. equi strains, whereas the other eight were
identified as members of the genus Dietzia, including Dietzia maris (four isolates), Dietzia natronolimnaea (two
isolates), and Dietzia timorensis and Dietzia sp. (one isolate each). The eight Dietzia isolates were highly sensitive
to 12 antimicrobial compounds.
The nocardioform actinomycete Rhodococcus equi is a mul-
tihost pathogen that causes pyogranulomatous infections in a
variety of animal species, with special significance in horses
and humans (23). In immunocompromised persons, R. equi
causes tuberculosis-like pneumonia associated with a high
case-fatality rate, particularly in human immunodeficiency vi-
rus (HIV)-infected patients (22). The number of cases of in-
fection associated with R. equi in humans increased with the
expansion of the AIDS pandemia but in recent years has di-
minished due to the control of HIV spread.
R. equi infections are diagnosed by culture and subsequent
phenotypic analysis of samples by means of classical morpho-
logical and biochemical tests (9). In clinical microbiology lab-
oratories, R. equi is usually identified using the API Coryne
system (bio-Me´rieux, Marcy l’E´toile, France), a commercial
multisubstrate kit that includes R. equi in its database. How-
ever, its reliability for the identification of rhodococcal isolates
is limited, resulting in misidentification of R. equi as other
rhodococcal species or even other actinomycetes (9). Several
molecular methods based on amplification of DNA sequences
by PCR for detection and identification of this pathogen have
been proposed. Since R. equi is particularly relevant in equine
medicine, most target the plasmid-borne vapA gene, encoding
a virulence factor associated with horse pathogenesis. How-
ever, these methods are not useful for human isolates, because
they generally do not carry vapA-type virulence plasmids but
alternative types, like the pig-associated vapB plasmid and a
recently identified new bovine type, or are plasmid-less (16).
We therefore developed a PCR method for species-specific R.
equi identification based on the amplification of the choE gene
(11, 20), a chromosomal locus encoding a secreted cholesterol
oxidase (14). ChoE is the cytolytic factor responsible for the
synergistic hemolysis (CAMP-like) reaction elicited by R. equi
in the presence of sphingomyelinase C-producing bacteria,
such as Listeria ivanovii, Bacillus cereus, and Staphylococcus
aureus (14). We use this CAMP-like reaction as a phenotypic
marker for the rapid presumptive identification of R. equi.
However, this functional test may miss R. equi isolates not
expressing cholesterol oxidase despite having the choE gene or
give false-positive results for other extracellular cholesterol
oxidase-producing actinomycetes.
During the last 5 years, 15 bacterial isolates with phenotypic
properties resembling those of rhodococci were collected from
human specimens and isolated at the Clinical Microbiology
Laboratory of the Hospital Marque´s de Valdecilla, Santander,
Spain. All of them were identified as R. equi by the API Coryne
test. However, several of these isolates showed colony mor-
phology and pigmentation characteristics that differed from
those typical of R. equi strains. The 15 isolates were addition-
ally tested with the CAMP assay and the R. equi-specific choE
PCR assay, and their 16S rRNA genes were sequenced. Anal-
ysis of 16S rRNA gene sequences provides reliable identifica-
tion at the species level for most of the clinically significant
bacteria (6).
CAMP tests were performed on sheep blood agar plates
with Columbia base medium (bioMe´rieux) and L. ivanovii
ATCC 19119 as the indicator strain, as described previously
(14). Highly purified genomic DNA samples from all the
strains under study were prepared by following a previously de-
scribed protocol for R. equi genomic DNA extraction (14). The R.
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equi-specific choE PCR was carried out with COX primers as
described in detail elsewhere (11). The universal primers PA
(5-AGAGTTTGATCCTGGCTCAG-3) and PL06 (5-GGTTA
AGTCCCGCAACGAGCGA-3) for the forward strand and PH
(5-AAGGAGGTGATCCAGCCGCA-3) and PLO6-R (5-GC
GCTCGTTGCGGGACTTAACC-3) for the reverse strand
were used to generate overlapping DNA amplicons from the 16S
rRNA genes. These amplicons were sequenced by primer walking
using dye terminator chemistry in an Applied Biosystems model
377 apparatus. Homology searches were performed with the
BLAST tool (1) at the website of the National Center for Bio-
technology Information (Bethesda, MD; http://www.ncbi.nlm.nih
.gov). The 16S rRNA gene sequences from the eight isolates
identified as Dietzia species (Table 1) were registered in the
GenBank database. A phylogenetic tree was inferred from
the aligned sequences by the neighbor-joining method (21).
Ten of the 15 isolates gave a positive CAMP test result with
L. ivanovii, whereas PCR amplification of the genomic DNA
samples with COX primers gave positive results for only 8
isolates. Sequencing of the 16S rRNA genes from all isolates
revealed that for eight isolates, the best match was a sequence
from the genus Dietzia. The genus Dietzia has been established
very recently and includes environmental isolates with great
resemblance in morphology and colony appearance to R. equi
(13). Several authors have reported the isolation of Dietzia
strains, notably Dietzia maris (3, 18) but also Dietzia papillo-
matosis (12) and Dietzia cinnamea (25), from human clinical
material. The 16S rRNA genes of isolates CA138, CA150,
CA160, and CA167 showed 99% identity to the correspond-
ing gene from D. maris strain DSM 43672 (Table 1), the type
strain of the genus Dietzia (15). D. maris has been isolated from
a variety of environments, including soils, deep sea mud, and
the dinoflagellate Pyrodinium bahamense (2). It has also been
recovered from the skin of healthy humans (8), and in four
instances, it has been associated with human infections. Be-
mer-Melchior et al. isolated D. maris from the blood of an
immunocompromised patient suffering septic shock and carry-
ing a long-term central line in situ (3). This D. maris isolate was
susceptible to -lactam agents, aminoglycosides, macrolides,
pristinamycin, rifampin, trimethoprim-sulfamethoxazole, and
vancomycin. D. maris was also identified as the causal agent of a
prosthetic hip infection (18). This isolate was susceptible to
amoxicillin, imipenem, gentamicin, pristinamycin, trimethoprim-
sulfamethoxazole, rifampin, clindamycin, and vancomycin. Reyes
et al. isolated D. maris from the pericardial liquid and the aortic
wall of a patient with aortitis (19). The isolate was susceptible to
teicoplanin, tobramycin, linezolid, rifampin, imipenem, cipro-
floxacin, gentamicin, vancomycin, clarithromycin, clindamycin,
and amoxicillin-clavulanic acid. Finally, Broseta et al. isolated D.
maris from the blood of a patient with cardiac and respiratory
insufficiency (5).
The 16S rRNA genes of two isolates, CA161 and CA165,
were 99% identical to that of Dietzia natronolimnaea CV46.
D. natronolimnaea strains have been isolated from salt lakes,
alkaline waters, and the guts of Japanese horned beetle (Try-
poxylus dichotomus) larvae (13). Morphologically, colonies
from isolate CA155 did not resemble those from the other five
isolates. The CA155 16S rRNA gene was 99% identical to that
from Dietzia timorensis ID05-A0528. This species was proposed
to classify a soil isolate from West Timor, Indonesia, and has
recently been validly recognized as a novel Dietzia species (24).
This is the first reported isolation of the alkaliphilic D. natrono-
limnaea and the recently established species D. timorensis from
human specimens. Finally, the 16S rRNA gene of isolate
CA149 was most similar (94.6%) to that of Dietzia schimae
YIM 65001. However, since the levels of identity of the CA149
16S rRNA gene to genes from D. schimae YIM 65001 and
other Dietzia spp. registered in GenBank were lower than 99%,
CA149 was assigned the identification Dietzia sp.
Figure 1 shows a phylogenetic tree based on 16S rRNA
genes depicting the relationships among the eight Dietzia iso-
lates identified in this study and representative strains of
Dietzia and R. equi. Isolate CA149 forms a detached branch in
the tree, whereas the other isolates group with a representative
Dietzia strain.
Previous reports by other authors and our own data suggest
that dietziae have the potential to act as opportunistic patho-
gens. To date, no comprehensive investigation of the suscep-
tibilities of human Dietzia isolates to antibiotics has been car-
ried out. The in vitro susceptibilities of the eight identified
Dietzia bacteria to antimicrobial agents were evaluated by the
Etest diffusion gradient method according to the instructions
of the Etest manufacturer (AB Biodisk, Solna, Sweden). The
guidelines of the CLSI for testing the antibiotic susceptibilities
TABLE 1. Identification of eight Dietzia isolates initially classified as R. equi or Rhodococcus sp.
Isolatea
Result of
CAMP test
(using L.
ivanovii)
API Coryne identification
Result of
choE-specific
PCR assay
Length (bp) of
16S rRNA
gene sequence
Identification based on 16S
rRNA gene sequence
(% identity to best match)
GenBank
accession
no. for 16S
rRNA gene
CA138  R. equi  1,424 D. maris DSM 43672 (99.8) GU247959
CA149  Rhodococcus sp.  1,467 D. schimae YIM 65001 (94.6) GQ870422
CA150  Rhodococcus sp.  1,468 D. maris DSM 43672 (99.7) GQ870423
CA155  Gordonia, Dietzia, or Nocardia
species or R. equi
 1,472 D. timorensis ID05-A0528 (99.6) GQ870424
CA160  Rhodococcus sp.  1,465 D. maris DSM 43672 (99.9) GQ870425
CA161  Rhodococcus sp.  1,433 D. natronolimnaea CV46 (99.5) GQ870426
CA165  R. equi  1,451 D. natronolimnaea CV46 (100) GQ870427
CA167  R. equi  1,373 D. maris DSM 43672 (100) GQ870428
ATCC 616106   D. maris
ATCC 6939   R. equi
a ATCC 616106 and ATCC 6939 are reference type strains of D. maris and R. equi, respectively.
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of mycobacteria, nocardiae, and other aerobic actinomycetes
(7) were followed. The antibiotics recommended by the CLSI,
including amikacin, amoxicillin-clavulanic acid, ceftriaxone,
ciprofloxacin, clarithromycin, trimethoprim-sulfamethoxazole
(cotrimoxazole), imipenem, linezolid, minocycline, and tobra-
mycin, were tested. Ampicillin and vancomycin were also
tested. Escherichia coli ATCC 25922 and S. aureus ATCC
25923 served as controls. Resistance or susceptibility to the
antibiotics was interpreted as suggested by the CLSI standards
(7). The results of susceptibility tests are given in Table 2. The
eight Dietzia isolates and ATCC 616106, a collection strain
representative of D. maris, were susceptible to all antibiotics
tested. D. maris has been reported previously to be susceptible
to aztreonam, ciprofloxacin, mezlocillin, oxacillin, penicillin G,
perfloxacin, and ticarcillin and to be resistant to sulfamethox-
azole by disk diffusion testing (4).
Our findings show that discrimination between R. equi and
Dietzia species is problematic in the clinical microbiology lab-
oratory and that in the absence of clear-cut markers, 16S
rRNA gene sequencing is required for accurate identification
of isolates of these species. Species-level identification based
on the full 16S rRNA gene sequence is considered to be the
“gold standard” for actinomycetes (17), but results must be
treated with caution for recently established and grossly un-
dercharacterized genera, such as Dietzia (13). In our case, eight
isolates erroneously identified as R. equi could be recognized
as members of the genus Dietzia and seven of them could be
identified at the species level.
FIG. 1. Neighbor-joining tree based on 16S rRNA gene sequences showing the phylogenetic relationships among isolates identified as Dietzia
and representative strains of Dietzia and R. equi. Bar, 1% sequence variation. The bifurcations are supported by the indicated bootstrap values.
TABLE 2. Antibiotic susceptibilities of the eight Dietzia isolates identified in this study
Isolate
MICa (g/ml) of:
AMK AMC AMP CRO CIP CLR COT IPM LZD MIN TOB VAN
D. maris isolate CA138 0.25 0.016 0.047 0.06 0.032 0.016 1 0.125 0.125 0.064 0.19 0.19
Dietzia sp. isolate CA149 0.50 0.016 0.500 0.750 0.016 0.016 0.094 0.064 0.250 0.032 0.500 0.500
D. maris isolate CA150 0.75 0.032 0.250 0.750 0.032 0.016 0.094 0.047 0.190 0.047 0.750 0.125
D. maris isolate CA160 0.50 0.032 0.250 0.250 0.047 0.016 0.032 0.064 0.380 0.125 0.190 0.500
D. maris isolate CA167 0.125 0.016 0.047 0.750 0.008 0.016 0.094 0.002 0.016 0.016 0.094 0.190
D. natronolimnaea isolate CA161 1.00 0.047 0.380 0.500 0.023 0.047 0.5 0.032 0.500 0.250 1.500 0.125
D. natronolimnaea isolate CA165 0.50 0.016 0.250 0.750 0.012 0.250 0.19 0.032 0.190 0.023 0.500 0.016
D. timorensis isolate CA155 0.125 0.016 0.750 0.750 0.032 0.120 0.25 0.064 0.032 0.064 0.023 0.500
R. equi ATCC 6939 2.00 0.016 0.380 0.094 0.047 0.016 0.064 0.012 0.190 0.064 0.125 0.750
D. maris ATCC 616106 0.064 0.016 0.023 0.032 0.006 0.016 0.016 0.750 0.125 0.500 0.190 0.250
a The MICs were determined by the Etest method. The medium used was Mueller-Hinton agar supplemented with sheep blood. AMK, amikacin; AMC,
amoxicillin-clavulanic acid; AMP, ampicillin; CRO, ceftriaxone; CIP, ciprofloxacin; CLR, clarithromycin; COT, cotrimoxazole; IPM, imipenem; LZD, linezolid; MIN,
minocycline; TOB, tobramycin; VAN, vancomycin. R. equi ATCC 6939 and D. maris ATCC 616106 were included as reference strains.
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Dietzia bacteria appear to be widely distributed in the envi-
ronment, and reports of isolates from clinical material are
increasing. D. maris was detected in skin samples from healthy
subjects in a recent characterization of the skin microbiota
using a 16S rRNA gene-based comprehensive analysis (8),
suggesting that it may be a normal human commensal. Our find-
ing of species of Dietzia, initially wrongly identified as R. equi, in
human clinical specimens highlights the potential importance of
members of this newly defined bacterial genus as opportunistic
human pathogens and the need for accurate methods to ensure
their correct identification in the clinical setting.
Nucleotide sequence accession numbers. The 16S rRNA gene
sequences from the eight Dietzia isolates were deposited in
GenBank under accession numbers GU247959 and GQ870422 to
GQ870428.
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